ACRC

SPEE3D to Manufacture Metal Parts for the Defense, Industrial, and Space Industries Onsite at RAPID + TCT Conference

Retrieved on: 
Monday, May 1, 2023

The company will manufacture parts onsite for various uses and industries, showcasing its patented cold spray additive manufacturing (CSAM) technology that enables on-demand production of critical parts in minutes and hours versus days.

Key Points: 
  • The company will manufacture parts onsite for various uses and industries, showcasing its patented cold spray additive manufacturing (CSAM) technology that enables on-demand production of critical parts in minutes and hours versus days.
  • ; printed in 18 minutes
    Rocket Nozzle Liner: A scaled-down example of a rocket nozzle used in the Space industry; 4.5 lbs.
  • ; printed in 32 minutes
    SPEE3D will have various other parts on display in the booth made of aluminum, aluminum bronze, and copper.
  • SPEE3D’s printers use Diversitech dust collectors to ensure that the air exiting SPEE3D systems is clean of any pollutants.

New Program Offers Critical Resources to the 34 million Americans Living with Lung Disease

Retrieved on: 
Tuesday, January 31, 2023

CHICAGO, Jan. 31, 2023 /PRNewswire/ -- More than 34 million Americans live with chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, lung cancer and other lung diseases. To provide these individuals and their families with critical support, education and access to emerging research like clinical trials, today, the American Lung Association announced the Patient & Caregiver Network.

Key Points: 
  • American Lung Association launches Patient & Caregiver Network to provide support, education and access to research for people with lung disease and their families
    CHICAGO, Jan. 31, 2023 /PRNewswire/ -- More than 34 million Americans live with chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, lung cancer and other lung diseases.
  • To provide these individuals and their families with critical support, education and access to emerging research like clinical trials, today, the American Lung Association announced the Patient & Caregiver Network .
  • Fortunately, new research is resulting in better treatments so that people with lung disease are living longer, healthier lives," said Harold Wimmer, National President and CEO of the American Lung Association.
  • "Our new Patient & Caregiver Network is the go-to resource for anyone living with a lung disease and their families."

First-Ever Millennial Lung Health Study Begins in Chicago

Retrieved on: 
Wednesday, May 11, 2022

CHICAGO, May 11, 2022 /PRNewswire/ -- Lung disease is now a leading cause of death in the country due to the increase in COVID-19 infections and related deaths. At a time when lung health is more important than ever, today, the American Lung Association and Northwestern Medicine announced they are now accepting participants in Chicago for a groundbreaking study of millennial lung health.

Key Points: 
  • At a time when lung health is more important than ever, today, the American Lung Association and Northwestern Medicine announced they are now accepting participants in Chicago for a groundbreaking study of millennial lung health.
  • The American Lung Association Lung Health Cohort is the first-ever large-scale lung healthstudythat will track 4,000 young adults (aged 25-35) at the age of peak lung health.
  • Here are some details about the American Lung Association Lung Health Cohort study:
    It will follow 4,000 young adults at the age of peak lung health, from 25 to 35 years old, in many different regions across the U.S., painting a clear picture of lung health across geography and demography.
  • To learn more about the American Lung Association Lung Health Cohort or to speak with a lung health expert or the principal investigator, contact Jill Dale at [email protected] or 312-940-7001.

Perioperative acetaminophen use significantly reduces opioid utilization and improves pain control following arthroscopic rotator cuff repair

Retrieved on: 
Tuesday, August 31, 2021

SAN DIEGO, Aug. 31, 2021 /PRNewswire/ -- Including acetaminophen for pain management prior to and after arthroscopic rotator cuff repair (ARCR) can significantly reduce opioid consumption and improve patient satisfaction post-surgery, according to a new study presented at the 2021 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). The study, "Effect of Perioperative Acetaminophen on Pain Management in Patients Undergoing Rotator Cuff Repair: A Prospective Randomized Study," also found that patients who took acetaminophen throughout the overall surgical process (pre-, during, and post-surgery) had better pain control, even while taking less opioids.

Key Points: 
  • The study, "Effect of Perioperative Acetaminophen on Pain Management in Patients Undergoing Rotator Cuff Repair: A Prospective Randomized Study," also found that patients who took acetaminophen throughout the overall surgical process (pre-, during, and post-surgery) had better pain control, even while taking less opioids.
  • [iv] Because of this, Dr. Abboud and his colleagues set out to study alternative options for post-surgical pain management.
  • Arthroscopic repair of massive rotator cuff tears: outcome and analysis of factors associated with healing failure or poor postoperative function.
  • Postoperative pain control after arthroscopic rotator cuff repair.